State-of-the-art laboratory infrastructure and sophisticated R&D services to support the development of the next wave of innovations in biotechnology.
Our vision is to become a global catalyst for life science innovation based in Greece.
Our mission is to advance drug discovery and development through scientific excellence and collaboration for the benefit of patients worldwide.
The Memorandum of Cooperation signed by Papageorgiou General Hospital and Athens LifeTech Park on Thursday, 8 October 2026, at the Hospital, opens up new possibilities for developing clinical studies and biomedical research in Greece.
On September 10th, Athens LifeTech Park officially opened its doors. Prime Minister Kyriakos Mitsotakis was there, alongside people from the life sciences and biotech world, many of them Greeks from the diaspora who never stopped believing in this country.
Kleanthis Xanthopoulos: A serial entrepreneur in biotechnology with a global footprint. Athens Life Tech Park, the Novartis acquisition and medicine... the American way.
Athens LifeTech Park is an ELPEN initiative, designed and executed in collaboration with leading scientists within Greece and internationally.
The Park operates as a stand-alone, not-for-profit entity (AMKE), overseen by an independent Board of Directors.
We believe Greece has the potential to play a key role in the global life sciences ecosystem by harnessing its exceptional scientific talent.
Join us in shaping the future of health and life sciences - your ideas, expertise, and passion can make a real difference. Get in touch and become part of our journey!